Pfizer beats earnings estimates as declining Covid business performs better than expected
January 30, 2024 at 07:16 AM EST
Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government.
